Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
7390760 | Value in Health Regional Issues | 2014 | 8 Pages |
Abstract
The Iranian drug reimbursement system uses decision-making criteria and a structured approach similar to those in other countries. Important shortcomings in the system include out-of-pocket contributions due to lengthy decision making, lack of transparency, and conflicting interests among stakeholders. Iranian policymakers should consider a number of ways to remedy these problems, such as case studies of individual drugs and closer examination of experiences in other countries.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Amir PharmD, Carin A. PhD, Adri PhD, PharmD, William K. PhD,